Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Mann

Showing results (151-160 of 161) with videos related to

Pageof 17
Sort By:
Neuron|September 28, 2011
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTDAlan E Renton, Elisa Majounie, Adrian Waite, et al.
Plos One|November 19, 2010
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's diseaseLesley Jones, Peter A Holmans, Marian L Hamshere, et al.
Nature Genetics|September 8, 2009
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseDenise Harold, Richard Abraham, Paul Hollingworth, et al.
Annals of Neurology|September 27, 2018
Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasiaDavid Bergeron, Maria L Gorno-Tempini, Gil D Rabinovici, et al.
Journal of Alzheimer'S Disease : JAD|October 27, 2011
The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's diseaseAmy Gerrish, Giancarlo Russo, Alexander Richards, et al.
Acta Neuropathologica|February 11, 2019
Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLDCyril Pottier, Yingxue Ren, Ralph B Perkerson, et al.
The Lancet. Neurology|May 5, 2018
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association studyCyril Pottier, Xiaolai Zhou, Ralph B Perkerson, et al.
Nature Genetics|April 5, 2011
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's diseasePaul Hollingworth, Denise Harold, Rebecca Sims, et al.
Nature Genetics|August 17, 2019
Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processingBrian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, et al.
Nature Genetics|March 2, 2019
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processingBrian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, et al.
Pageof 17

Showing results (151-160 of 161) with videos related to

Sort By:
Pageof 17
Neuron|September 28, 2011
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTDAlan E Renton, Elisa Majounie, Adrian Waite, et al.
Plos One|November 19, 2010
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's diseaseLesley Jones, Peter A Holmans, Marian L Hamshere, et al.
Nature Genetics|September 8, 2009
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseDenise Harold, Richard Abraham, Paul Hollingworth, et al.
Annals of Neurology|September 27, 2018
Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasiaDavid Bergeron, Maria L Gorno-Tempini, Gil D Rabinovici, et al.
Journal of Alzheimer'S Disease : JAD|October 27, 2011
The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's diseaseAmy Gerrish, Giancarlo Russo, Alexander Richards, et al.
Acta Neuropathologica|February 11, 2019
Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLDCyril Pottier, Yingxue Ren, Ralph B Perkerson, et al.
The Lancet. Neurology|May 5, 2018
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association studyCyril Pottier, Xiaolai Zhou, Ralph B Perkerson, et al.
Nature Genetics|April 5, 2011
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's diseasePaul Hollingworth, Denise Harold, Rebecca Sims, et al.
Nature Genetics|August 17, 2019
Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processingBrian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, et al.
Nature Genetics|March 2, 2019
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processingBrian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, et al.
Pageof 17